04/07/2026
Ozempic is exploding in popularity.
Millions of people are now taking it for weight loss.
It’s being called a breakthrough.
But some are asking a different question:
Should we automatically trust it?
Ozempic is made by Novo Nordisk, a major pharmaceutical company backed by large institutional investors, including BlackRock and Vanguard. These same global investment firms hold shares across the wider pharmaceutical industry, including companies behind COVID-era products.
For some, that overlap raises questions about financial incentives when blockbuster drugs are rolled out to millions.
There are also known side effects already documented:
Nausea
Vomiting
Diarrhoea
Constipation
Significant appetite suppression
Lean mass (muscle) loss during weight loss
Gallbladder issues linked to rapid weight loss
Pancreatitis (rare but serious)
And that’s just what’s currently known.
When a drug is taken by millions of people in a short space of time, long-term effects often only become clearer later. Appetite suppression may lead to under-eating. Rapid weight loss may affect muscle and metabolism. These are questions that only wider, longer-term use can fully answer.
So the conversation isn’t just about losing weight.
It’s about how that weight is lost…
and what happens to the body over time.
Before choosing a drug that forces appetite down, some people are asking whether it makes more sense to support the body’s natural systems instead, metabolism, cravings, digestion and energy, and allow weight to follow.
